KAT2A and cancer: In various cancers, GCN5 acts in a rather oncogenic fashion [9,10,11,12], which is usually ascribed to its function as a coactivator of the c-MYC (V-Myc Avian Myelocytomatosis Viral Oncogene Homolog) oncogene protein [13,14,15].